Related Experiment Videos
Chronotherapeutics for cardiovascular disease
1Department of Medicine, University of Connecticut School of Medicine, Farmington, USA.
Drugs
|May 20, 1998
Summary
Chronotherapeutics, a novel medication delivery, aligns drug release with the body's 24-hour circadian rhythm. This approach aims to improve treatment for cardiovascular diseases like hypertension and angina by targeting peak physiological needs.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Chronobiology
Background:
- Cardiovascular diseases exhibit predictable daily (circadian) variations in incidence.
- Ambulatory monitoring reveals significant variability in blood pressure and myocardial ischemia in patients.
- Chronotherapeutics offers a new approach to tailor medication delivery to physiological needs.
Purpose of the Study:
- To introduce chronotherapeutics as a novel approach for cardiovascular disease management.
- To highlight the development and theoretical advantages of controlled onset, extended release (COER-24) verapamil.
- To describe the ongoing CONVINCE study evaluating COER-24 verapamil for cardiovascular event prevention.
Main Methods:
- Utilizing epidemiological data on circadian rhythms of cardiovascular events.
- Employing advanced ambulatory monitoring for blood pressure and electrocardiogram.
- Developing and testing controlled onset, extended release (COER-24) drug formulations.
- Conducting outcome studies (e.g., CONVINCE) to compare chronotherapy with standard care.
Main Results:
- Chronotherapeutics aims to match drug delivery to the body's natural circadian rhythms.
- COER-24 verapamil is designed to optimize coverage during early morning hours, a period of high cardiovascular risk.
- An international outcome study (CONVINCE) is evaluating the efficacy of this chronotherapy.
Conclusions:
- Chronotherapeutics represents a promising advancement in managing cardiovascular conditions.
- Tailored drug delivery, exemplified by COER-24 verapamil, may offer improved therapeutic benefits.
- Further research through outcome studies is crucial to confirm the clinical impact of chronotherapy.